SLN
Silence Therapeutics PLC
10.80$
-3.6%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +106.7% | -9.3% | -1.4% | -29.3% | +18.5% | +86.6% | +11.9% | +11.8% | -12.1% | +71.2% | -18.8% | |
| – | +140.8% | -21.5% | +8.4% | -35.2% | +27.0% | +103.9% | +13.0% | +12.0% | -15.6% | +83.3% | -20.7% | |
| – | +207.9% | -24.8% | +9.6% | -49.7% | -37.1% | +103.1% | +167.9% | -25.5% | -0.7% | +78.0% | -88.4% | |
| – | +137.5% | -24.8% | +10.4% | -38.4% | +26.3% | +11.7% | +96.4% | -3.3% | -23.5% | +116.2% | -27.7% | |
| – | +286.7% | -44.1% | +147.5% | +22.0% | -99.8% | +732,550.0% | -98.9% | +176.4% | +1,973.7% | -95.9% | +3,070.4% | |
| – | – | – | – | – | – | – | -100.0% | -1,642,700,100.0% | – | – | – | |
| – | – | – | -14.9% | -21.3% | -33.7% | +84.5% | +72.5% | +13.2% | – | – | – | |
| – | -5.8% | +15.7% | +4.2% | +1.2% | -5.4% | +5.6% | -6.6% | +5.5% | +24.6% | -24.8% | +41.6% | |
| – | +200.0% | +650.0% | -37.8% | +128.6% | -46.9% | -50.0% | +41.2% | +1,233.3% | +13.1% | -31.2% | +15.6% | |
| – | -44.5% | +44.0% | +65.0% | +44.1% | +557.1% | +205.6% | +14.0% | -2.6% | -9.7% | -28.9% | +26.2% | |
| – | -44.5% | +44.0% | +65.0% | +44.1% | +152.0% | +164.9% | -40.7% | +44.7% | -19.4% | -24.0% | +1.3% | |
| – | – | – | – | – | – | +18.8% | -59.8% | +225.5% | -59.5% | -48.2% | -4.8% | |
| – | -89.7% | +155.1% | -12.5% | +148.3% | +56.1% | +27.7% | +77.9% | -21.6% | -16.8% | +11.5% | +49.3% | |
| – | +117.7% | -10.3% | -3.4% | -33.0% | -40.4% | -56.7% | -5.9% | +158.9% | -0.4% | +386.7% | -41.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.0% | +9.0% | +0.2% | +0.5% | +6.8% | +8.8% | +8.8% | -63.8% | +15.2% | +24.7% | +2.1% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.